Posts by Sandra Ansanay-Alex
MindMaze Therapeutics Narrows Losses and Prepares for Commercial Takeoff in 2026
MindMaze Therapeutics’ 2025 Annual Report tells a story of transition—one where financial discipline begins to align with long-term commercial ambition. The Swiss-based neurotechnology company gears up for a broader market launch in 2026. Mindmaze reported CHF 0.6 million in revenue for 2025, alongside operating expenses of CHF 11.2 million and a net loss of CHF…
Read MoreUNBOOUND Medical Technology SA Awarded CHF 100,000 by FONGIT
UNBOOUND Medical Technology SA has been awarded CHF 100,000 in FIF Seed Tech funding for its standardised olfactory assessment platform. UNBOOUND Medical Technologies SA is a medtech startup and spin-off from The Rockefeller University (New York), developed in close collaboration with the Geneva University Hospitals (HUG) and the University of Geneva. The company addresses a…
Read MoreCosaic Secures $6 Million Seed Extension
The University of Fribourg (UNIFR) spinoff announced a $6 million round, that includes participation from dsm-firmenich Ventures, the venture arm of dsm-firmenich, a global leader in Health, Nutrition and Beauty. Also joining the round are a large Swiss family office and Kickfund, a Swiss deeptech investor, as well as existing investors such as Navus Ventures…
Read MoreHealthtech Investor Summit
The Healthtech Investor Summit is taking place from 30 November to 2 December 2026 in Bruges (Belgium) The Healthcare Investors Summit is a unique event bringing together innovative companies and investors across the full spectrum of health technologies. Rather than focusing on a specific segment, the Summit is driven by a common goal: advancing solutions…
Read Moreplanetary Raises CHF 16 Million to Advance Microprotein Production
planetary, a Geneva-based startup developing sustainable food ingredients through fermentation, has secured a CHF 16 million Series A funding round, complemented by CHF 6 million in credit. Over the last few month, the startup raises nearly CHF 34 million. The new financing will support the expansion of its fermentation infrastructure and the development of its…
Read MoreSeprify and BIOGRUND Join Forces
SilvaAlba™, a plant-based cellulose alternative to titanium dioxyde will developed by Seprify will be used by BIOGRUND, a specialist in coating solutions.
Read MoreFour Vaud-based Projects Awarded FIT Impact Grants
Four innovative projects from the canton of Vaud have each been awarded a CHF 10,000 grant from the FIT Fondation pour l’Innovation Technologique through its FIT Impact program. Emerging from University of Lausanne (UNIL) and the H4 ecosystem, the selected initiatives—FineTouch Academy, Phonemia, SODA, and TYTOdb—address key challenges in healthcare, education, and environmental monitoring. FineTouch…
Read MoreONWARD Medical secures €40 million
ONWARD Medical has successfully raised more than €40 million in a capital increase, marking a significant milestone in its mission to restore movement and independence in people with spinal cord injuries. The financing round includes a €25 million investment from EQT Life Sciences, alongside strong support from leading institutional and sector-specialist investors. This new funding…
Read MoreThree Life Sciences Companies Finalist of the Strategis Award
The jury of the Prix Strategis selected five companies, to advance to the final round of the competition. Three of them are Swiss Health Valley projects. Irmos Technologies AG, which develops solutions to extend the lifespan of infrastructure. Neology SA, which offers a clean alternative to diesel. Virtuosis AI, specialized in intelligent vocal biomarkers. Isospec…
Read MoreEPFL Innogrants
Five EPFL-based life sciences startups, Alpion CryoSolutions, Eleum, Feedback Intuitive, MOLECL, and NourishAI are the latest recipients of the EPFL Startup Launchpad Innogrant and Innogrant for biotherapeuthics. Each team has secured CHF 100,000 to accelerate the development of their technology. Alpion CryoSolutions Cryo-electron microscopy has transformed biology by allowing researchers to see proteins in extraordinary detail. However, existing…
Read More